×

Align Technology to add directors, launch review after deal with Elliott

By Thomson Reuters Jul 29, 2026 | 3:52 PM

July 29 (Reuters) – Align Technology will add three new independent directors to its board and launch a review of its operations following talks with activist investor Elliott ​Investment Management, the company said on Wednesday.

Shares of the ‌medical device maker were down 4.5% in extended trading.

The three new board members, who have not yet been named, will be chosen for their expertise in healthcare technology, medical devices, global operations, and scaling high-growth ‌businesses.

Elliott, ​one of Wall Street’s most prominent activist ⁠investors, has increasingly turned ⁠its attention to healthcare companies over the past year, often pushing for board representation and strategic reviews to boost performance.

Elliott’s recent targets in the sector have included Dexcom, Medtronic ​and Charles River Laboratories.

Align has hired a leading global consulting firm to conduct a comprehensive review of its operations and ⁠business model. The company said the ⁠review will focus on improving revenue growth and ​boosting profit margins.

The changes follow discussions with Elliott, which has ​emerged as one of Align’s largest shareholders.

Align manufactures dental ‌retainers, scanners and software for dental laboratories and practitioners, and is widely regarded as a leader in the dental technology market alongside peers such as Envista, Dentsply Sirona and Henry Schein.

Align ⁠rose to prominence as the maker of Invisalign, the clear dental aligner system that disrupted traditional braces and helped transform orthodontics through digital ⁠scanning and treatment ‌planning.

Marc Steinberg, a partner at Elliott, in ⁠a statement called Align a market leader with ​significant ‌growth potential. “We believe the board enhancements and ​other actions…are important ⁠steps toward delivering on this opportunity,” he said.

The company said it raised its share buyback target for the year to between $400 million and $500 million, up from $200 million, citing confidence in its long-term value.

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Sahal Muhammed ​and Shailesh Kuber)